Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dual chemo combo with great results

<< Previous

Bullboard Posts

Next >>

Comment by wildbird1on Feb 16, 2023 9:11pm

178 Views

Post# 35291253

RE:Dual chemo combo with great results

NOtaPOOp maybe you should learn to read...

The 82 % in your article is for High-Risk(NMIBC) these are the regular patients that BCG treat, with about the same CR% results.

TLT is treating BCG-Resistant (NMIBC) absolutely not the same patients...if TLT was treating the same patients as in your article(High-Risk NMIBC) TLT CR% could easily be over 90-95% CR.

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?